These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9639772

  • 1. [Prenatal screening for Down's syndrome].
    Qin Q, Christiansen M, Norgaard-Pedersen B.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract] [Full Text] [Related]

  • 2. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA.
    Tsitol Genet; 1998 Nov; 32(1):66-71. PubMed ID: 9695254
    [Abstract] [Full Text] [Related]

  • 3. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 4. [Prenatal diagnosis of Down's syndrome: prediction from maternal serum markers].
    Zilberstein T, Maymon E.
    Harefuah; 1998 Mar 01; 134(5):393-6. PubMed ID: 10909560
    [No Abstract] [Full Text] [Related]

  • 5. Prenatal cytogenetic screening.
    Simpson JL.
    Ultrasound Obstet Gynecol; 1995 Jan 01; 5(1):3-5. PubMed ID: 7531607
    [No Abstract] [Full Text] [Related]

  • 6. Repeated measures screening for Down's Syndrome.
    Wright DE, Bradbury I.
    BJOG; 2005 Jan 01; 112(1):80-3. PubMed ID: 15663402
    [Abstract] [Full Text] [Related]

  • 7. [Maternal serum screening for Down's syndrome].
    Muller F.
    Ann Biol Clin (Paris); 2002 Jan 01; 60(6):689-92. PubMed ID: 12446233
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improving methods of screening for Down's syndrome.
    White I, Papiha SS, Magnay D.
    N Engl J Med; 1989 Feb 09; 320(6):401-2. PubMed ID: 2464139
    [No Abstract] [Full Text] [Related]

  • 11. Multiple marker screening.
    Dickerson VM.
    West J Med; 1994 Aug 09; 161(2):161. PubMed ID: 7524245
    [No Abstract] [Full Text] [Related]

  • 12. Oligosaccharide variants of hCG-related molecules: potential screening markers for Down syndrome.
    Cole LA, Cermik D, Bahado-Singh R.
    Prenat Diagn; 1997 Dec 09; 17(12):1188-90. PubMed ID: 9467819
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening for Down's syndrome. Serum screening programmes are effective and safe.
    Wald NJ, Hackshaw AK, Huttly W.
    BMJ; 2000 Sep 23; 321(7263):763-4; author reply 764-5. PubMed ID: 10999927
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical screening for congenital defects.
    Bahado-Singh RO, Sutton-Riley J.
    Obstet Gynecol Clin North Am; 2004 Dec 23; 31(4):857-72, xi. PubMed ID: 15550339
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
    Guibaud S, Boisson C, Chambon V, Simplot A.
    Ann Biol Clin (Paris); 1998 Dec 23; 56(4):439-44. PubMed ID: 9754279
    [Abstract] [Full Text] [Related]

  • 20. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Sep 23; 32(4):488-92. PubMed ID: 18726925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.